No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
VTv Therapeutics Appoints Barry Brown as Interim CFO
This Couchbase Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
VTv Therapeutics Analyst Ratings
H.C. Wainwright Initiates VTv Therapeutics(VTVT.US) With Buy Rating, Announces Target Price $36
Promising Potential of VTv Therapeutics' Cadisegliatin in Addressing Unmet Needs in Type 1 Diabetes
VTv Therapeutics Resumes Phase 3 Trial for Cadisegliatin